Time | Topics | Speaker/s | Discussant |
09:00
-
09:05
|
Prevalence and Causes of Visual Impairment and Blindness in Central Iran: the Yazd Eye Study
|
Mojgan Pakbin,
|
Seyed Farzad Mohammadi, MD
|
09:09
-
09:14
|
a Journey into the Blind Patients' World: a Hermeneutic Phenomenological Study
|
Mahmood Shamshiri, PhD
|
Hamid Ahmadieh, MD
|
09:18
-
09:23
|
Ru-106 Plaque Radiotherapy for Treatment of Retinoblastoma
|
Arezoo Astaraki, MD
|
Saeed Karimi, MD
|
09:27
-
09:32
|
Ophthalmic Artery Chemosurgery (OAC) for Retinoblastoma
|
Arezoo Astaraki, MD
|
Fariba Ghasemi, MD
|
09:36
-
09:41
|
the Effect of Fasudil, a Rho-Associated Protein Kinase Inhibitor, on the Intraocular Pressure
|
Mohammad Pakravan, MD
|
Naveed Nilforushan, MD
|
09:45
-
09:50
|
Peri-Papillary Retinal Nerve Fiber Layer Changes after Pan-Retinal Photocoagulation for Diabetic Retinopathy
|
Pourya Samadi, MD
|
Ghasem Fakhraie, MD
|
09:54
-
09:59
|
Evaluation of Asymptomatic Cardiac Disease in Ocular Pseudoexfoliation
|
Maryam Yadegari, MD
|
Reza Zarei, MD
|
10:03
-
10:07
|
Erythropoietin: a Novel Treatment for Methanol Associated Optic Neuropathy
|
Farzad Pakdel, MD
|
Mostafa Soltan Sanjari, MD
|
10:11
-
10:16
|
Cornea Epithelial Tissue Regeneration by Cell Sheet /Biodegradable Membrane
|
Alireza Baradaran Rafii, MD
|
Fatemeh Tabandeh, PhD
|
10:20
-
10:25
|
Improving the Ophthalmic Laser Systems by Stimulating and Calculating the Laser Beam Spot Intensity on the Retina Using a Computer Model and Clinical OCT Data
|
Azadeh Soleimani,
|
Mohammad Esmail Zibaii, PhD
|